SNGX SOLIGENIX INC Investments/Divestments 8-K Filing 2023 - Investment Agreement Soligenix, Inc. has entered into an exclusive option agreement with Silk Road Therapeutics to acquire a topical formulation for the treatment of mucocutaneous ulcers in patients with Behçet's Disease.Get access to all SEC 8-K filings of the SOLIGENIX INC